ArticleMolecular therapy. Nucleic acids2026
The lncRNA, CyKILRb acts as a ceRNA for tumor suppressive microRNA to augment oncogenic phenotype via induction of PIK3R2/PI
Xiujie Xie, H Patrick Macknight, Barbara Dziegielewska, Amy L Lu, Ngoc Thanh Vu, Charles E Chalfant
Abstract read
In one paragraphArticle in Molecular therapy. Nucleic acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Xiujie XieDepartment of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA 22903, USA.
H Patrick MacknightDepartment of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA 22903, USA.
Barbara DziegielewskaDepartment of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA 22903, USA.
Amy L LuDepartment of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA 22903, USA.
Ngoc Thanh VuDepartment of Applied Chemistry, School of Biotechnology, International University, Ho Chi Minh City, Vietnam.
Charles E ChalfantDepartment of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA 22903, USA.
Funding
Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1MTissue Repository and Animal Models CoreP01CA171983 · NCI · UNIVERSITY OF VIRGINIA · PI CHALFANT, CHARLES E. · 2013 to 2024
$19.9MProject 3P01CA302570 · NCI · UNIVERSITY OF VIRGINIA · PI Thomas P. Loughran · 2025 to 2026
$7.8MThe roles of ceramide and its derivatives in A. phagocytophilum pathogenesisR01AI139072 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHARLES E. CHALFANT, Jason A Carlyon · 2018 to 2026
$5.7MiPLA2beta-mediated alternative splicing and -cell death in type 1 diabetesR01DK126444 · NIDDK · UNIVERSITY OF VIRGINIA · PI CHALFANT, CHARLES E., EIZIRIK, DECIO LAKS · 2021 to 2024
$2.0MRegulation of ceramide-1-phosphate metabolism in cell signaling networksR01GM155691 · NIGMS · UNIVERSITY OF VIRGINIA · PI CHARLES E. CHALFANT · 2025 to 2026
$707kBLRD VA I01 BX001792BLRD VA I01 BX006063NCI NIH HHS P01 CA171983NCI NIH HHS P01 CA302570NCI NIH HHS P30 CA044579NIAID NIH HHS R01 AI139072NIDDK NIH HHS R01 DK126444NIGMS NIH HHS R01 GM155691ORD VA I01 RD001334ORD VA IK6 RD002739
6 · The paper itselfAbstract
The lncRNA CyKILR produces two splice variants with antagonistic roles in lung tumorigenesis. While its nuclear counterpart functions as a tumor suppressor, we revealed that the cytoplasmic variant, CyKILRb, is a potent oncogenic driver that activates the PI
Indexed as
AKTCyKILRlong noncoding RNAsmicroRNAsmiR-3151-5pMT: non-coding RNAsnon-small cell lung cancersPI3KPIK3R2RNA splicing
Identifiers
PMID42662823
PMCPMC13520900
What Socratic holds
Textmetadata
Read underepoch 390